West Pharma (WST) Tops Q3 EPS by 26c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $385.73 -1.15%
Revenue Growth %: -6.5%
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Revenue Growth %: -6.5%
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q3 EPS of $2.06, $0.26 better than the analyst estimate of $1.80. Revenue for the quarter came in at $706.5 million versus the consensus estimate of $687.09 million.
GUIDANCE:
West Pharma sees FY2021 EPS of $8.40-$8.50, versus the consensus of $8.21. West Pharma sees FY2021 revenue of $2.8-2.81 billion, versus the consensus of $2.8 billion.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- First Bancorp. (FBNC) Misses Q1 EPS by 2c
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
